GOOD SHEPHERD PENN PARTNERS — History
CCN 392050 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$66M
Latest Revenue (FY2022)
+13.2%
Revenue CAGR (3yr)
-78.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $52M | $57M | $66M | +16.1% | +13.2% |
| Operating Expenses | $109M | $112M | $118M | +5.3% | +4.2% |
| Operating Margin | -100.0% | -97.1% | -78.7% | +19.0% | +0.0% |
| Net Income | $-57M | $-55M | $-52M | +5.9% | +0.0% |
| Licensed Beds | 18 | 18 | 18 | +0.0% | +0.0% |
| Total Patient Days | 5,120 | 3,981 | 5,342 | +34.2% | +2.1% |
| Medicare Day % | 30% | 42% | 36% | -13.9% | +9.2% |
| Medicaid Day % | 8% | 7% | 8% | +11.9% | -2.6% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +28.2% ($52M → $66M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+13.2%
This Hospital
+7.6%
State Avg
Latest Margin
-78.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $73M | -68.0% |
| FY2024 (proj) | $81M | -57.4% |
| FY2025 (proj) | $88M | -46.7% |